import React from 'react';

export let chapter_twelve = {
    short_title: "Chapter 12",
    long_title: "Malaria",
    subsections: [{
      short_title: "Section 1",
      long_title: "General Notes",
      content:
        <span>
          <h2>General Notes</h2>
          <ul>
            <li> The pattern of malaria varies geographically.
        <em>Plasmodium falciparum</em> causes almost all the malaria in Zimbabwe. A few cases of malaria due to <em>P.vivax, P.ovale</em> and <em>P.malariae</em> may be seen.</li>
            <li> Complications occur mainly with <em>P.falciparum</em> and usually in young children, pregnant women, adults in epidemic prone areas and people moving from areas of no malaria to areas with malaria including immune compromised patients and sicklers.</li>
            <li> Malaria dcptrial occurs 1-6 weeks after a bite by an infected female anopheles mosquito. So it is important to take a good history and to always ask about travel and self-medication. </li>
          </ul>
        </span>
    },
    {
      short_title: "Section 1",
      long_title: "Malaria Prevention",
      content:
        <span>
          <h2>Malaria Prevention</h2>
          <p>Social and behaviour change communication on non-pharmacological means of prevention is extremely important e.g. indoor residual spraying, use of mosquito coils, repellents, long lasting insecticide-treated mosquito nets, appropriate protective clothing.</p>
        </span>
    },
    {
      short_title: "Section 2",
      long_title: "Medicine Prophylaxis",
      content:
        <span>
          <h2>Medicine Prophylaxis</h2>
          <p>Due to lack of evidence of efficacy on antimalarial prophylaxis in Zimbabwe coupled with suspected poor performance of the previously used medicines, personal protection is highly recommended. This is to avoid providing false sense of protection to those visiting malarious areas. Personal protection can be achieved by sleeping under a net, use of repellents when visiting a malarious area, putting on long sleeved clothes at dusk or dawn and getting indoors early. Where medicines are used, it is important to note that no medicine gives 100% protection against malaria, but medicines do reduce the risk. However, chemoprophylaxis is recommended in pregnant women as indicated below:</p >
          <p><strong>Malaria prophylaxis for:</strong></p>
          <p>Intermittent Preventive Treatment (IPTp)</p>
          <ul>
            <li>
              <strong>Pregnant women in regions of moderate to high transmission.</strong>
            </li>
          </ul>
          <p>Chemoprophilaxis in this group in based on an assumption that every pregnant woman in a malaria-endemic area is infected with malaria and has malaria parasites in the blood or in the placenta. The medication is given as treatment doses at prescribed intervals.</p>
          <ul>
            <li>Three tablets of SP (each SP tablet contains Sulphadoxine 500 mg and Pyrimethamine 25 mg) are given at booking (after quickening).</li>
            <li>Give SP to all pregnant women at each scheduled ANC visit up to time of delivery</li>
            <li>The doses should not be less than 4 weeks apart</li>
            <li>SP should ideally be given as directly observe therapy of three tablets</li>
            <li>SP can be given on either an empty stomach or with food</li>
            <li>SP should NOT be administered to women receiving Co-trimoxazole prophylaxis due to a higher risk of adverse effects</li>
            <li>It is recommended that weekly folic acid also be given to pregnant woman taking IPTp. (This is done in conjuction with the Reproductive Health Department).</li>
          </ul>
          <p><a><strong>Malaria prophylaxis for:</strong>
          </a></p>
          <ul>
            <li>
              <strong>visitors from outside the country</strong>
            </li>
          </ul>
          <p>May continue with the prophylaxis recommended to them before coming to Zimbabwe, but personal protection should be emphasized.</p>
  
        </span>
    },
    {
      short_title: "Section 3",
      long_title: "Treatment of Malaria",
      content:
        <span>
          <h2>Treatment of Malaria</h2>
          <p><strong>All antimalarial medicines should be administered only to confirmed cases</strong> (Confirmation is done by RDT or Malaria Blood Slide). However in children less than five years treatment may be initiated whilst awaiting blood results provided other causes of fever have been clinically excluded.</p>
          <p>Malaria blood slides <strong>MUST</strong> be taken in the following cases:</p>
          <ul>
            <li> Patients with severe/ complicated malaria.</li>
            <li> Patients with treatment failure.</li>
            <li> All referrals.</li>
            <li> All cases where Co-artemether has been used in the preceding 2 weeks</li>
          </ul>
          <p>Note: Pregnant women diagnosed with malaria <strong>must</strong> receive medicine therapy immediately. Although quinine is potentially teratogenic, the benefit of giving quinine therapy far outweighs any risk.</p>
  
        </span>
    },
    {
      short_title: "Section 4",
      long_title: "Uncomplicated Malaria",
      content:
        <span>
          <h2>Uncomplicated Malaria</h2>
          <p>The first line treatment of uncomplicated malaria is the arteminisinin combined therapy Artemether-lumefantrine (Co-artemether).</p>
          <table>
            <tr><td></td><td>Medicine</td><td colspan="2">Codes</td><td><p>Dose</p></td><td>Frequency</td><td>Duration</td></tr>
            <tr><td></td><td><p><strong>artemether-lumefantrine po</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>See table below</p></td><td></td><td></td></tr>
          </table>
          <p>(Co-artemether) Artemether-Lumefantrine (1.5mg/12mg/kg):</p>
          <p>To be given as a 6 dose course of tablets twice a day for 3 days as follows:</p>
          <table>
            <tr><td colspan="2"><p><strong>Dosage</strong></p> </td><td><p><strong>Day 1</strong></p> </td><td><p><strong>Day 2</strong></p> </td><td><p><strong>Day 3</strong></p> </td></tr>
            <tr><td><p>Weight (kg)</p></td><td><p>Lts Age (yrs)</p></td><td><p>Start After Dose 8hrs*</p> </td><td><p>AM PM</p></td><td><p>AM PM</p></td></tr>
            <tr><td><p>5- 14</p></td><td><p>&lt;3</p></td><td><p>1 1</p></td><td><p>1 1</p></td><td><p>1 1</p></td></tr>
            <tr><td><p>15-24</p></td><td><p>3-8</p></td><td><p>2 2</p></td><td><p>2 2</p></td><td><p>2 2</p></td></tr>
            <tr><td><p>25-34</p></td><td><p>9-14</p></td><td><p>3 3</p></td><td><p>3 3</p></td><td><p>3 3</p></td></tr>
            <tr><td><p>&gt;35</p></td><td><p>&gt;14</p></td><td><p>4 4</p></td><td><p>4 4</p></td><td><p>4 4</p></td></tr>
          </table>
          <p><strong>Note:</strong></p>
          <ul>
            <li>*Strictly after 8 dcptrial </li>
            <li>Parasitological proof of malaria by blood slide or rapid diagnostic test (RDT) is desirable whenever Arteminisin based combination is used</li>
            <li>Tablet of Co-artemether- is a fixed dose formulation of(Artemether 20mg/Lumefantrine120mg)</li>
          </ul>
          <p><strong>N.B</strong>:</p>
          <ol>
            <li> If the initial dose of Co-artemether is vomited within 30 minutes repeat dose. </li>
            <li> If vomiting is persistent treat as severe/complicated malaria.</li>
            <li> If no improvement within 48 hours change to oral Artesunate/amiodiaquine.</li>
            <li> To ensure compliance it is desirable to give the STAT doses as Directly Observed Therapy (DOT).</li>
            <li> Malaria in the 1 <sup>st</sup> trimester of pregnancy should be treated with a 7 day course of oral quinine and clindamycin.</li>
          </ol>
          <p><strong>TREATMENT IN SPECIAL GROUPS</strong></p>
          <p>Uncomplicated malaria in infants not eligible for treatment with Co-artemether</p>
          <p><strong>Treatment of infants under 5kg body weight</strong></p>
          <table>
            <tr><td></td><td>Medicine</td><td colspan="2">Codes</td><td><p>Dose</p></td><td>Frequency</td><td>Duration</td></tr>
            <tr><td></td><td><p><strong>quinine po</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>10mg per Kg body weight</p> </td><td><p>Every 8 hours</p></td><td><p>7 days</p></td></tr>
          </table >
          <p><strong>Uncomplicated malaria in pregnancy</strong></p>
          <table>
            <tr><td colspan="10">
              <p><strong>TRIMESTER/APPROXIMATE GESTATION</strong></p> </td></tr>
            <tr><td colspan="2"><p><strong>1
                    <sup>st</sup>
              trimester-before quickening</strong></p> </td><td colspan="8">
                <p><strong>2
                    <sup>nd</sup>
                  and 3
                    <sup>rd</sup>
                  trimester –after quickening</strong></p> </td></tr>
            <tr><td rowspan="2">
              <p><strong>Medicine</strong></p> </td><td rowspan="2"></td><td rowspan="2">
                <p><strong>Medicine</strong></p> </td><td colspan="3">
                <p>DAY1</p></td><td colspan="2"><p>DAY2</p></td><td colspan="2"><p>DAY 3</p></td></tr>
            <tr><td><p>STAT</p></td><td><p>After 8 hrs</p></td><td colspan="2"><p>AM</p></td><td><p>PM</p></td><td><p>AM</p></td><td><p>PM</p></td></tr>
            <tr><td><p><strong>Quinine tab</strong></p> </td><td><p>600mg every 8 hrs for 7 days</p> </td><td><p><strong>Co-artemether</strong></p>
              <p>(No. Of tablets)</p></td><td><p>4</p></td><td><p>4</p></td><td colspan="2"><p>4</p></td><td><p>4</p></td><td><p>4</p></td><td><p>4</p></td></tr>
            <tr><td><p><strong>Clindamycin tab</strong></p>
            </td><td><p>300mg every 8 hours for 7 days</p></td><td colspan="8"></td></tr >
          </table>
          <ul>
            <li><a>Twelve hours apart from day 2 to day 3</a>
            </li>
          </ul>
        </span>
    },
    {
      short_title: "Section 5",
      long_title: "Treatment Failure",
      content:
        <span>
          <h2>Treatment Failure</h2>
          <p>Early treatment failure is formally diagnosed if a patient is still febrile 72hrs after initial therapy and has more than 25% of initial asexual parasitaemia.</p>
          <p>Treatment failure however should be suspected clinically if there is no response after 48 hours of correct therapy, and a change to second line therapy made immediately.</p>
          <p>Late treatment failure is the recurrence of fever and asexual parasitaemia 7-14 days after initial successful treatment.</p>
          <p>Treatment failure may be due to:</p>
          <ul>
            <li> Inadequate therapy, e.g. medicine being vomited within 30 minutes, under dosing or failure to complete the treatment.</li>
            <li> Presence of undetected severe and complicated malaria. </li>
            <li> Malaria parasite resistance (known or suspected) to the given medicine.</li>
          </ul>
          <p>If a patient returns to the health facility still feeling unwell:</p>
          <ul>
            <li> Check for other conditions e.g. ARI, gastro-enteritis </li>
            <li> Check for signs of severe and complicated malaria</li>
            <li> Take a blood slide</li>
          </ul>
          <p>If there are no signs of severe/complicated malaria give the following treatment immediately:</p>
          <p><strong>Second Line Therapy</strong> –</p>
          <table>
            <tr><td><p><strong>Medicine</strong></p> </td><td><p><strong>Codes</strong></p> </td><td><p><strong>Dose</strong></p> </td><td><p><strong>Frequency</strong></p> </td><td><p><strong>Duration</strong></p> </td></tr>
            <tr><td><p><strong>Artesunate/Amodiaquine po</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>As per table below</p></td><td><p>Once daily</p></td><td><p>3 days</p></td></tr>
          </table>
          <p><em>Each tablet of AS-AQ may contain Artesunate 25mg and Amodiaquine 67.5mg, Artesunate 50mg and Amodiaquine 135mg OR Artesunate 100mg and Amodiaquine 270mg</em></p>
          <p><em>Dosage is 4mg/kg body weight Artesunate and 10mg/kg Amodiaquine base taken once daily orally for three days.</em></p>
          <table>
            <tr><td><p><strong>Weight range (approximate age range)</strong></p> </td><td><p><strong>Dosage</strong></p> </td><td><p><strong>Day 1</strong></p> </td><td><p><strong>Day 2</strong></p> </td><td><p><strong>Day 3</strong></p> </td></tr>
            <tr><td><p><strong>≥5kg to &lt;9kg</strong></p>
              <p><strong>(2 -11 months)</strong></p> </td><td><p>25mg Artesunate + 67.5 mg Amodiaquine</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td></tr>
            <tr><td><p><strong>≥9kg to &lt;18kg</strong></p>
              <p><strong>(1 year- 5 years)</strong></p> </td><td><p>50mg Artesunate + 135mg Amodiaquine</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td></tr>
            <tr><td><p><strong>≥18kg to 36kg</strong></p>
              <p><strong>( 6-13 years)</strong></p> </td><td><p>100mg Artesunate + 270mg Amodiaquine</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td><td><p>1 Tablet</p></td></tr>
            <tr><td><p><strong>≥36kg</strong></p>
              <p><strong>(14 years and above) </strong></p> </td><td><p>100mg Artesunate + 270mg Amodiaquine</p></td><td><p>2 Tablets</p></td><td><p>2 Tablets</p></td><td><p>2 Tablets</p></td></tr>
          </table >
          <p><strong>Second line treatment of uncomplicated malaria in adults unable to tolerate Artesunate-Amodiaquine is Oral Quinine with doxycycline or clindamycin</strong></p>
          <p><em>Each Quinine tablet contains quinine sulphate 300mg</em></p >
          <p><strong>Treatment schedule for second line therapy: Adults</strong></p>
          <table>
            <tr><td></td><td>Medicine</td><td colspan="2">Codes</td><td><p>Dose</p></td><td>Frequency</td><td>Duration</td></tr>
            <tr><td></td><td><p><strong>quinine po</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>600mg</p></td><td><p>Every 8 hours</p></td><td><p>7 days</p></td></tr>
            <tr><td></td><td><p><strong>doxycline po</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>100mg</p></td><td><p>Once daily</p></td><td><p>30 days</p></td></tr>
            <tr><td><p>or</p></td><td><p><strong>clindamycin po</strong></p> </td><td><p><strong>B V</strong></p> </td><td><p>300mg</p></td><td><p>Every 8hrs</p></td><td><p>7 days</p></td></tr>
          </table>
          <table>
            <tr><td><p><strong>7 Day Quinine Course</strong></p> </td></tr>
          </table>
          <table>
            <tr><td><p><strong>Medicine</strong></p> </td><td><p><strong>Codes</strong></p> </td><td><p><strong>Dose</strong></p> </td><td><p><strong>Frequency</strong></p> </td><td><p><strong>Duration</strong></p> </td></tr>
            <tr><td rowspan="2">
              <p><strong>quinine po</strong></p> </td><td><p><strong>B V</strong></p> </td><td><p>Adults 600 mg</p></td><td><p>Every 8 hours</p></td><td><p>7 days</p></td></tr>
            <tr><td colspan="2"><p>Children 10 mg/kg body weight</p></td><td><p>Every 8 hours</p></td><td><p>7 days</p></td></tr>
          </table>
          <table>
            <tr><td colspan="5">
              <p><strong>Short Course Quinine plus Doxycycline or Clindamycin (Adult)</strong></p> </td></tr>
            <tr><td><p><strong>Medicine</strong></p> </td><td><p><strong>Codes</strong></p> </td><td><p><strong>Dose</strong></p> </td><td><p><strong>Frequency</strong></p> </td><td><p><strong>Duration</strong></p> </td></tr>
            <tr><td><p><strong>quinine po</strong></p> </td><td><p><strong>B V</strong></p> </td><td><p>600 mg</p></td><td><p>Every 8 hours</p></td><td><p>5 days</p></td></tr>
            <tr><td><p><strong>clindamycin po</strong></p> </td><td><p><strong>B V</strong></p> </td><td><p>300mg</p></td><td><p>Every 8 hours</p></td><td><p>5 days</p></td></tr>
            <tr><td><p><strong>doxycycline po*</strong></p> </td><td><p><strong>C V</strong></p> </td><td><p>100 mg</p></td><td><p>Once daily</p></td><td><p>7 days</p></td></tr>
          </table>
          <p><em>N.B:-</em></p>
          <p><em>1. Duration of quinine</em>
            <em>may be shortened to 5 days if doxycycline</em>
            <em>is also given.</em></p>
          <p><em>2. *Doxycycline is contraindicated in children below 10 years and in pregnancy and these patients should complete the 7 day quinine</em>
            <em>course.</em></p >
  
        </span>
    },
    {
      short_title: "Section 6",
      long_title: "Severe / Complicated Malaria",
      content:
        <span>
          <h2>Severe / Complicated Malaria</h2>
          <p>This is a life threatening condition, and the goal of management therefore is to prevent death. Therapy should be initiated without delay.</p>
          <p>Check for signs of:</p>
          <ul>
            <li> prostration, i.e. if the patient is unable to stand or sit or feed independently,(children will be unable to breastfeed)</li>
            <li> persistent vomiting,</li>
            <li> the slightest sign of alteration in consciousness which may indicate cerebral malaria (refer to the Coma Scale).</li>
          </ul>
          <p>Complications include any of the</p>
          <ul>
            <li> Cerebral malaria</li>
            <li> Bleeding tendencies</li>
            <li> Severe anaemia (Hb≤6g/dl) ; (Hb &lt; 7.5g/dl for Non immune Patients)</li>
            <li> Hyperpyrexia</li>
            <li> Jaundice</li>
            <li> Shock</li>
            <li> Severe haemoglobinuria</li>
            <li> Hyperparasitaemia (&gt;5% in non- immune patients) </li>
            <li> Acute renal failure</li>
            <li> Respiratory distress</li>
            <li> Hypoglycaemia</li>
          </ul>
          <p>Treatment of severe/complicated malaria must be parenteral and the medicine of choice is artesunate while quinine will remain a usable option.</p>
          <p><strong>
            <u>Treatment at Health DCPtrial </u>
          </strong></p>
          <p>Parenteral therapy with artesunate injection must be commenced at primary level using IM administration or, if it is practical,  by IV infusion before the patient is referred. Treatment is initiated by a loading dose of artesunate or quinine.</p>
          <p>Artesunate 60mg injection (V, C) is used as follows:</p>
          <p>Dosage at 2.4 mg /kg (comprehensive dosage schedule).</p>
          <table>
            <tr><td><p>Weight</p></td><td><p>5kg-25kg</p></td><td><p>26kg-50kg</p></td><td><p>51kg-75kg</p></td><td><p>76kg-100kg</p></td></tr>
            <tr><td><p>60mg vial</p></td><td><p>1</p></td><td><p>2</p></td><td><p>3</p></td><td><p>4</p></td></tr>
          </table>
          <p><strong>Instructions for dilution</strong> of parenteral Artesunate for IV use.</p>
          <p>Reconstitute the artesunate powder with the 1ml of sodium bicarbonate ampoule provided. The solution will initially look cloudy. Wait for 1 minute for it to clear. Discard the solution if it does not clear. Add 5 mls of 5% dextrose water or N/saline to the reconstituted solution. The resultant 6ml solution will contain 10mg per ml of Artesunate. Check the dose to administer on the table below.</p>
          <p><strong>Dosing Schedule</strong></p>
          <ul>
            <li>Give a minimum of 3 parenteral doses of Artesunate once started before changing to oral treament, even if the patient is able to take oral medication early</li>
            <li>Prepare a fresh solution for each injection</li>
            <li>IV injection is given as slow bolus, about 4 mls per minute.</li>
            <li>Discard any unused solution.</li>
          </ul>
          <p><strong>Dosing schedule</strong></p >
          <table>
            <tr><td><p>Day 1</p></td><td><p>Day 1</p></td><td><p>Day 2</p></td><td><p>Day 3</p></td><td><p>Day 4</p></td><td><p>Day 5</p></td><td><p>Day 6</p></td><td><p>Day 7</p></td></tr>
            <tr><td><p>Stat</p>
              <p>Dose 1</p></td><td><p>12 hrs</p>
                <p>Dose 2</p></td><td><p>24 hrs</p>
                <p>Dose 3</p></td><td><p>Daily</p>
                <p>Dose 4</p></td><td><p>Daily</p>
                <p>Dose 5</p></td><td><p>Daily</p>
                <p>Dose 6</p></td><td><p>Daily</p>
                <p>Dose 7</p></td><td><p>Daily</p>
                <p>Dose 8</p></td></tr>
          </table >
          <p><strong>Check the dose to give intravenously on table below: </strong></p >
          <table>
            <tr><td><p><strong>Weight</strong></p> </td><td><p><strong>Dose (mg)</strong></p> </td><td><p><strong>Volume (ml)</strong></p> </td></tr>
            <tr><td><p>5-8 kg</p></td><td><p>20</p></td><td><p>2</p></td></tr>
            <tr><td><p>9-12 kg</p></td><td><p>30</p></td><td><p>3</p></td></tr>
            <tr><td><p>13-16 kg</p></td><td><p>40</p></td><td><p>4</p></td></tr>
            <tr><td><p>17-20 kg</p></td><td><p>50</p></td><td><p>5</p></td></tr>
            <tr><td><p>21-25 kg</p></td><td><p>60</p></td><td><p>6</p></td></tr>
            <tr><td><p>26-29 kg</p></td><td><p>70</p></td><td><p>7</p></td></tr>
            <tr><td><p>30-33 kg</p></td><td><p>80</p></td><td><p>8</p></td></tr>
            <tr><td><p>34-37 kg</p></td><td><p>90</p></td><td><p>9</p></td></tr>
            <tr><td><p>38-41 kg</p></td><td><p>100</p></td><td><p>10</p></td></tr>
            <tr><td><p>42-45 kg</p></td><td><p>110</p></td><td><p>11</p></td></tr>
            <tr><td><p>46-50 kg</p></td><td><p>120</p></td><td><p>12</p></td></tr>
            <tr><td><p>51-54 kg</p></td><td><p>130</p></td><td><p>13</p></td></tr>
            <tr><td><p>55-58 kg</p></td><td><p>140</p></td><td><p>14</p></td></tr>
            <tr><td><p>59-62 kg</p></td><td><p>150</p></td><td><p>15</p></td></tr>
            <tr><td><p>63-66 kg</p></td><td><p>160</p></td><td><p>16</p></td></tr>
            <tr><td><p>67-70 kg</p></td><td><p>170</p></td><td><p>17</p></td></tr>
            <tr><td><p>71-75 kg</p></td><td><p>180</p></td><td><p>18</p></td></tr>
            <tr><td><p>76-79 kg</p></td><td><p>190</p></td><td><p>19</p></td></tr>
            <tr><td><p>80-83 kg</p></td><td><p>200</p></td><td><p>20</p></td></tr>
            <tr><td><p>84-87 kg</p></td><td><p>210</p></td><td><p>21</p></td></tr>
            <tr><td><p>88-91 kg</p></td><td><p>220</p></td><td><p>22</p></td></tr>
            <tr><td><p>92-95 kg</p></td><td><p>230</p></td><td><p>23</p></td></tr>
            <tr><td><p>96-100 kg</p></td><td><p>240</p></td><td><p>24</p></td></tr>
          </table>
          <ul>
            <li>Once the patient is able to take oral medication switch to oral Co-artemether for a full three day course (<em>see Table for Co-artemether course</em>).</li>
            <li>If the patient is unable to take any oral medication continue with intravenous Artesunate for a total of seven days (<em>see Table above</em>).</li>
            <li>Continue to evaluate the patient regularly for improvement or deterioration.</li>
          </ul>
          <ul>
            <li>Continue supportive treatment and monitoring as required in all patients with severe malaria.</li>
          </ul>
          <p><strong>PREPARING ARTESUNATE FOR IM USE:</strong></p>
          <p><strong>1. RECONSTITUTE ( Activate the Artesunate powder by mixing with 1ml of bicarbonate provided)</strong></p >
          <p><img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.090.png" width="90" height="56"
            alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.091.png" width="125" height="65"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.092.png" width="126" height="51"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.093.png" width="103" height="57"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.094.png" width="106" height="60"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.095.png" width="134" height="65"
              alt="" /></p>
          <p><img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.096.png" width="44" height="14"
            alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.096.png" width="44" height="14"
              alt="" /></p>
          <p><img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.099.png" width="34" height="8"
            alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.098.png" width="31" height="8"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.097.png" width="34" height="8"
              alt="" /></p >
          <p><strong>2. DILUTE ( Add 2mls normal saline solution or 5% dextrose to each vial of Reconstituted Artesunate)</strong></p>
          <p><strong>CAUTION ! : Do not use water for injection !</strong></p>
          <p><img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.100.png" width="98" height="62"
            alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.101.png" width="100" height="62"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.102.png" width="126" height="54"
              alt="" />
            <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.103.png" width="112" height="54"
              alt="" /></p>
          <ol>
            <li>
              <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.106.png" width="45" height="8"
                alt="" />
              <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.105.png" width="55" height="8"
                alt="" />
              <img src="edliz-2015-final-version-with-signatures/edliz-2015-final-version-with-signatures.104.png" width="43" height="8"
                alt="" />
            </li>
            <li></li>
          </ol >
          <ol start="3">
            <li>CHECK THE DOSE TO GIVE ON TABLE BELOW: </li>
          </ol>
          <table>
            <tr><td><p><strong>Weight</strong></p> </td><td colspan="2"><p><strong>&lt;5kg</strong></p> </td><td><p><strong>5-8kg</strong></p> </td><td><p><strong>9-12kg</strong></p> </td><td><p><strong>13-16kg</strong></p> </td><td><p><strong>17-20kg</strong></p> </td><td><p><strong>21-25kg</strong></p> </td><td><p><strong>26-29kg</strong></p> </td><td><p><strong>30-33kg</strong></p> </td><td><p><strong>34-37kg</strong></p> </td><td><p><strong>38-41kg</strong></p> </td><td><p><strong>42-45kg</strong></p> </td><td><p><strong>46-50kg</strong></p> </td><td><p><strong>51-54kg</strong></p> </td><td><p><strong>55-58kg</strong></p> </td><td><p><strong>59-62kg</strong></p> </td></tr>
            <tr><td><p><strong>Dose (mg)</strong></p> </td><td><p><strong>10</strong></p> </td><td colspan="2"><p><strong>20</strong></p> </td><td><p><strong>30</strong></p> </td><td><p><strong>40</strong></p> </td><td><p><strong>50</strong></p> </td><td><p><strong>60</strong></p> </td><td><p><strong>70</strong></p> </td><td><p><strong>80</strong></p> </td><td><p><strong>90</strong></p> </td><td><p><strong>100</strong></p> </td><td><p><strong>110</strong></p> </td><td><p><strong>120</strong></p> </td><td><p><strong>130</strong></p> </td><td><p><strong>140</strong></p> </td><td><p><strong>150</strong></p> </td></tr>
            <tr><td><p><strong>Volume (ml)</strong></p> </td><td><p><strong>1</strong></p> </td><td colspan="2"><p><strong>1</strong></p> </td><td><p><strong>2</strong></p> </td><td><p><strong>2</strong></p> </td><td><p><strong>3</strong></p> </td><td><p><strong>3</strong></p> </td><td><p><strong>4</strong></p> </td><td><p><strong>4</strong></p> </td><td><p><strong>5</strong></p> </td><td><p><strong>5</strong></p> </td><td><p><strong>6</strong></p> </td><td><p><strong>6</strong></p> </td><td><p><strong>7</strong></p> </td><td><p><strong>7</strong></p> </td><td><p><strong>8</strong></p> </td></tr >
          </table >
          <table>
            <tr><td><p><strong>Weight</strong></p> </td><td><p><strong>63-66kg</strong></p> </td><td><p><strong>67-70kg</strong></p> </td><td><p><strong>71-75kg</strong></p> </td><td><p><strong>76-79kg</strong></p> </td><td><p><strong>80-83kg</strong></p> </td><td><p><strong>84-87kg</strong></p> </td><td><p><strong>88-91kg</strong></p> </td><td><p><strong>92-95kg</strong></p> </td><td><p><strong>96-100kg</strong></p> </td></tr>
            <tr><td><p><strong>Dose (mg)</strong></p> </td><td><p><strong>160</strong></p> </td><td><p><strong>170</strong></p> </td><td><p><strong>180</strong></p> </td><td><p><strong>190</strong></p> </td><td><p><strong>200</strong></p> </td><td><p><strong>210</strong></p> </td><td><p><strong>220</strong></p> </td><td><p><strong>230</strong></p> </td><td><p><strong>240</strong></p> </td></tr>
            <tr><td><p><strong>Volume (ml)</strong></p> </td><td><p><strong>8</strong></p> </td><td><p><strong>9</strong></p> </td><td><p><strong>9</strong></p> </td><td><p><strong>10</strong></p> </td><td><p><strong>10</strong></p> </td><td><p><strong>11</strong></p> </td><td><p><strong>11</strong></p> </td><td><p><strong>12</strong></p> </td><td><p><strong>12</strong></p> </td></tr>
          </table >
          <ul>
            <li>
              <strong>Administer injection slowly.</strong>
            </li>
            <li>
              <strong>IM Injection volumes greater than 5 mls should be spread over different injection sites.</strong>
            </li>
          </ul>
          <p><strong>OR</strong></p>
          <ul>
            <li>
              <strong>IN ADULTS</strong> administer quinine intravenously:</li>
          </ul>
          <ul>
            <li>IV quinine loading dose of 20mg per Kg body weight diluted in 500ml of Normal saline or 5% dextrose water infused over 4 hours. Do not exceed 1200mg of loading dose. After 8 hours subsequent doses should be administered at 10mg per Kg body weight diluted in Normal Saline or 5% dextrose water.</li>
          </ul>
          <p><strong>Additional Supportive measures for patients with severe malaria awaiting transfer:</strong></p>
          <ul>
            <li>Maintain airway by appropriately positioning the patient in a left lateral position with the chin extended if patient is in a coma or convulsing. Administer oxygen if available. Patients with pulmonary oedema should be propped up and given IV diuretics.</li>
            <li>Give IV 25% dextrose water for hypoglycaemia in children as 1ml 50% dextrose per Kg body weight diluted 1:1 with water for injection. This can also be given orally or via nasogastric tube if IV access is not readily secured. Where the child is still able to; continue to breastfeed.</li>
            <li>Parenteral anti-emetics can be administered in adults with persistent vomiting.</li>
            <li>Address hyperpyrexia through physical means such as tepid sponging and fanning. Antipyretics such as Paracetamol may be given where appropriate.</li>
            <li>Where available treat convulsions with either intravenous or rectal diazepam.</li>
          </ul>
          <p><strong>
            <em>A CLEAR LEGIBLE REFERRAL LETTER STATING THE DATE, NAME OF PATIENT, BRIEF HISTORY, DIAGNOSIS AND THE PRE REFERRAL TREATMENT GIVEN SHOULD ACCOMPANY THE PATIENT TO THE NEXT LEVEL OF CARE</em>
            .
              <em>COMPLETE THE MALARIA REFERRAL FORM</em>
          </strong></p >
          <p><strong>If IV Artesunate is unavailable, IV Quinine is the alternative for patients with severe malaria.</strong></p >
          <p><strong>NOTE</strong>: Intravenous quinine is the medicine of choice to treat <strong>SEVERE MALARIA in children weighing less than 5kg and dcptrial women in the first trimester </strong>.</p>
          <p>Note: Do not use a loading dose if the patient has taken quinine in the preceding 24-48 hours (or mefloquine in the preceding 7 days).</p>
          <table>
            <tr><td></td><td>Medicine</td><td colspan="2">Codes</td><td>Adult Dose</td><td>Frequency</td><td>Duration</td></tr>
            <tr><td rowspan="2"></td><td><p><strong>quinine infusion</strong> in 5% dextrose</p></td><td><p><strong>B V</strong></p> </td><td rowspan="2">
              <p>20mg/kg</p></td><td colspan="2" rowspan="2">
                <p>over 4 hours, monitor infusion rate carefully,</p></td></tr>
            <tr><td colspan="3">
              <p><em>(max loading dose = 1200mg)</em></p> </td></tr>
            <tr><td></td><td colspan="3">
              <p><strong>then after 8hrs</strong>:</p>
              <p><strong>then</strong></p>
              <p><em>(max maintenance dose = 600mg)</em></p> </td><td><p>10mg/kg</p></td><td colspan="2"><ul>
                <li>over next 4 hours, </li>
                <li>repeat every 8 hours until able to tolerate oral therapy.</li>
              </ul></td></tr>
            <tr><td></td><td colspan="3">
              <p><strong>then reduce to</strong></p> </td><td><p>5mg/kg</p></td><td><p>every 8 hrs</p></td><td><p>*</p></td></tr >
          </table>
          <p>*Note: Change to oral therapy if the patient can swallow. Give the equivalent dose of quinine salt orally to complete 7 days of treatment.</p >
          <p><strong>Cautions:</strong> Quinine may have toxic effects even at this dosage - headache, confusion, nausea, tinnitus, tremors,
            abdominal pain, rashes, temporary visual disturbances and reversible deafness. Hypersensitivity reactions may occur rarely.Attention should therefore be paid to the dose per body weight, and the change to oral therapy made as soon as possible.</p>
          <ul>
            <li> Full size adults are generally assumed to weigh 60kg. The loading dose is therefore 1200mg and maintenance 600mg. Never exceed this dose <strong>even if</strong> the patient weighs more than 60kg.</li>
            <li> All efforts should be made to weigh adolescents or “small adults” to avoid overdosing those who might be far less than 60kg. If weighing is not possible assume to be 45 kg. </li>
            <li> Hypoglycaemia is an important problem with IV quinine. Monitor blood glucose 4hrly. If there is any deterioration of consciousness, hypoglycaemia should be considered. The infusion fluid (Dextrose 5%) is NOT for the specific correction of hypoglycaemia. Hypoglycaemia should be treated with the appropriate agents.</li>
          </ul>
          <p>When an IV line cannot be established:</p>
          <table>
            <tr><td></td><td colspan="2">Medicine</td><td colspan="2">Codes</td><td>Adult Dose</td><td>Frequency</td><td>Duration</td></tr>
            <tr><td></td><td><p><strong>quinine im *</strong></p> </td><td colspan="2"><p><strong>B V</strong></p> </td><td><p>10mg/kg</p></td><td><p>every 4 hrs</p></td><td><p>for 3 doses, then</p></td></tr>
            <tr><td></td><td></td><td colspan="2"></td><td></td><td><p>10mg/kg</p></td><td><p>every 8hrs</p></td><td><p>7 days</p></td></tr >
          </table>
          <ul>
            <li> DCPtrial referred to the district hospital after receiving a loading dose of IM quinine should be commenced on IV quinine 8 hours after the last dose of IM quinine was given. </li>
          </ul>
          <p>The duration of the dcptrial course may be shortened to 5 days if doxycycline is added to the therapy – see under Treatment Failure previous pages.</p>
          <p>*IM quinine should be diluted as follows:</p>
          <p>Dilute the quinine with water for injection. Draw 8ml of water for injection into a 10ml syringe, and then draw 2ml of quinine injection into the same syringe. The syringe now contains 10ml of a concentration of 60mg of quinine salt per ml. If the volume to be injected is greater than 3ml then give half into each thigh</p>
          <p>General measures</p>
          <ul>
            <li> Coma: maintain airway, nurse on side, and exclude other causes of coma, 2 hourly turns. </li>
            <li> Convulsions: treat appropriately and check for hypoglycaemia.</li>
            <li> Hypoglycaemia: monitor blood glucose, correct with dextrose 50% 1ml/kg (diluted 1 to 1) in children, 20-50ml in adults followed by dextrose 10% infusion.</li>
            <li> Severe anaemia: transfusion of packed cells if HB &lt; 6g/dl.</li>
            <li> Acute pulmonary oedema: review fluid balance. Monitor infusion rates carefully. If over-hydrated give IV frusemide.</li>
            <li> Acute renal failure: exclude pre-renal causes, check fluid balance, dialyse early.</li>
            <li> Check carefully for meningitis - do a lumbar puncture if necessary.</li>
          </ul>
        </span>
    },
    {
      short_title: "Section 1",
      long_title: "Treatment at Community Level",
      content:
        <span>
          <h2>Treatment at Community Level</h2>
          <p>When a patient presents with signs and symptoms of severe malaria as a referral from the community health worker he/she may have been given rectal artesunate if they were unable to take any medication orally and time to get to the referral centre was more than 6 hours.</p>
          <ul>
            <li>
              <strong>Rectal artesunate is given as follows</strong>:</li>
          </ul>
          <p><strong>
            <em>The dose of rectal artesunate is 10mg per Kg Body weight.</em>
          </strong></p>
          <ul>
            <li>Where the weight of the patient is not immediately known use the table below:</li>
          </ul>
          <table>
            <tr><td><p><strong>AGE</strong></p> </td><td><p><strong>ARTESUNATE DOSE</strong></p> </td><td><p><strong>ROUTE</strong></p> </td></tr>
            <tr><td><p><strong>6 months-1 YEAR</strong></p> </td><td><p>50MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
            <tr><td><p><strong>&gt;1 -3 YEARS</strong></p> </td><td><p>100MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
            <tr><td><p><strong>&gt;3 -5 YEARS</strong></p> </td><td><p>200MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
            <tr><td><p><strong>&gt;5-13 YEARS</strong></p> </td><td><p>300MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
            <tr><td><p><strong>14-15 YEARS</strong></p> </td><td><p>400MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
            <tr><td><p><strong>≥16 YEARS</strong></p> </td><td><p>600MG STAT</p></td><td><p>PER RECTUM</p></td></tr>
          </table>
          <p><strong>
            <em></em>
          </strong></p>
          <p><strong>
            <em>The weight of patients above 16yrs and all fully grown up adults has been assumed to be an average of 60kg. When artesunate is given according to known body weight do not exceed 1200mg.</em>
          </strong></p>
          <ul>
            <li>Do not give rectal artesunate to children weighing less than 5kg (less than 6 months).</li>
            <li>suppositories come in doses of 50mg, 100mg, 200mg and 400mg per suppository. </li>
            <li>To get to the required dose, 1 or more suppositories can be given in to get to the total dose required being considerate not to exceed three suppositories. </li>
            <li>If the suppository is expelled within 30 minutes, the dose should be repeated by insertion of another suppository.</li>
            <li>In children the buttocks can be held together for ten minutes to ensure retention.</li>
            <li>Once the rectal artesunate has been given the patient is immediately referred to the nearest health centre for further management without further delay.</li>
          </ul >
        </span>
    },],
    content:
      <span> </span>
  }